成人病的临床试验
总计380000个结果
-
The Affiliated Hospital of Qingdao UniversityChenland Nutritionals Inc.完全的
-
Auzone Biological Technology Pty LtdTIGERMED AUSTRALIA PTY LIMITED; CMAX Clinical Research Pty Ltd完全的
-
Ministry of Health, MalaysiaUniversiti Sains Malaysia主动,不招人
-
Astellas Pharma Global Development, Inc.FibroGen完全的
-
University of British ColumbiaAjinomoto Co., Inc.完全的
-
University of North Carolina, Chapel HillUniversity of Texas at Austin完全的
-
Danone Research完全的
-
Danone Research完全的
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)终止
-
National Cancer Institute (NCI)完全的
-
Bristol-Myers Squibb完全的
-
isRed Pharma & Biotech Research CorporationYung Shin Pharmaceutical Ind. Co., Ltd.未知
-
Bristol-Myers Squibb完全的
-
University of North Carolina, Chapel Hill完全的
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Bukwang Pharmaceutical完全的
-
Harokopio UniversityHellenic Republic Ministry of Development; Jotis S.A. Food Industry完全的
-
Washington University School of MedicineAmerican Cancer Society, Inc.完全的心血管疾病 | Young Adult Cancer Survivors美国
-
National Cancer Institute (NCI)完全的复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)完全的
-
Northwestern UniversityNational Cancer Institute (NCI); Bayer完全的
-
National Cancer Institute (NCI)完全的
-
Shengke Pharmaceuticals (Jiangsu) Limited, China招聘中